From BZ Small Cap Event: Can-Fite CEO Highlights Co.'s Drug Development Pipeline: Piclidenoson For Psoriasis, COVID-19, Namodenoson For Liver Cancer, NASH, CF602 For Erectile Dysfunction and Ongoing Pre-Clinical Trials For Cannabinoids